Picture EBD Group ChinaBio Partnering Forum 2022 650x100
Collaboration › Details

Twist Bioscience–Baird: investor conference, 202109 supply service Twist Bioscience presents at Baird 2021 Global Healthcare Conference


Period Period 2021-09-14
Organisations Partner, 1st Twist Bioscience Corporation (Nasdaq: TWST)
  Group Twist Bioscience (Group)
  Partner, 2nd Baird (Group)
Products Product Baird Global Healthcare Conference 2021 DIGITAL
  Product 2 DNA synthesis
Persons Person LeProust, Emily M. (Twist Bioscience 2013– CEO + Co-Founder before Agilent Director Genomics Application Development)
  Person 2 Thorburn, Jim (Twist Bioscience 202106 CFO)

Twist Bioscience Corporation. (9/9/21). "Press Release: Twist Bioscience to Present at Baird 2021 Global Healthcare Conference". South San Francisco, CA & Ingelheim.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present virtually at the Baird 2021 Global Healthcare Conference on September 14 at 4:20 p.m. Eastern Time.

The fireside chat will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chat will be archived for a period of 30 days following the conclusion of the live event.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

Angela Bitting
SVP, Corporate Affairs
925- 202-6211

Record changed: 2021-09-14


Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

More documents for Twist Bioscience (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px

» top